BLAINJECTIONINJECTABLEPriority Review
Approved
May 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
Priority Review
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VITRASE (hyaluronidase, ovine) is an injectable enzyme that breaks down hyaluronic acid in subcutaneous tissues, used to enhance the dispersion and absorption of other injected drugs or fluids. It functions as a spreading agent to improve drug delivery and reduce tissue trauma during infiltration. The product is a biologic therapeutic adjunct rather than a primary treatment agent.
LOE Approaching
Product is approaching loss of exclusivity with limited commercial team headcount, signaling potential workforce contraction or portfolio rotation within Bausch + Lomb.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (7)
Assessment of Intravitreous Injections of Vitrase for Inducing Posterior Vitreous Detachment
Started Jul 2005
10 enrolled
Vitreous DetachmentDiabetic Retinopathy
Evaluation of Vitrase as a Spreading Agent
Started Oct 2004
108 enrolled
Pain
Evaluation of Vitrase as an Adjuvant to Increase Absorption and Dispersion of Other Injected Anesthetics
Started Sep 2004
40 enrolled
Pain
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
Started Jul 2004
65 enrolled
Drug Hypersensitivity
Hypersensitivity Reaction to Vitrase (Ovine Hyaluronidase)
Started Mar 2004
65 enrolled
Drug Hypersensitivity
Worked on VITRASE at Bausch + Lomb? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.